850 Interim results for phase 1b dose expansion of MTL-CEBPA in combination with pembrolizumab in patients with advanced solid tumour malignanciesRuth Plummer, Nagy Habib, Jeffrey Yachnin et al.|Regular and Young Investigator Award Abstracts|2022Cited by 1